MGMT and glioblastoma: These results have been used as proof of efficacy of TMZ also for GBM patients with unmethylated MGMT. 37 Of importance, there was no difference in progression-free survival between the 2 treatment arms, indicating that any survival benefit in the combination arm would be due to treatment received after TMZ, at first progression.